We recently published a list of 12 Undervalued Defensive Stocks for 2025. In this article, we are going to take a look at ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...

Financial writer analysis of Arcutis Biotherapeutics, Inc. stock surge and potential growth, FDA approvals, and partnerships ...

Amgen's dividend profile shines, but growth slows. See why AMGN stock faces regulatory risks and offers limited incentives ...

The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against other best cheap stocks to buy for 2025. The U.S. consumer prices report released this week revealed a ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

A Danville woman is headed to Montour County court after allegedly charging more than $1,300 to an account she was not ...

Here are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...

Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...